Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

Similar documents
MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

Definition: fibrosis and nodular regeneration resulting from hepatocellular injury

Management of Cirrhosis Related Complications

Denver Shunts vs TIPS for Ascites

Liver failure &portal hypertension

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV

Chronic Hepatic Disease

Ascites. Matthew Johnson M.D.

End-Stage Liver Disease (ESLD): A Guide for HIV Physicians

Complications of Cirrhosis

ESLD a Guide for HIV Physicians. Marion Peters University of California San Francisco June 2015

Conflict of interest disclosures. Complications of end stage liver disease. None. The many complications of Cirrhosis. Portal Hypertension.

VARICEAL BLEEDING. Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta.

PORTAL HYPERTENSION An Introduction to the Culprit of Many Liver Failure Complications

Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC

Decompensated chronic liver disease

Index. Note: Page numbers of article titles are in boldface type.

The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist. K V Speeg, MD, PhD UT Health San Antonio

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

Etiology of liver cirrhosis

Complications of Cirrhosis

Causes of Liver Disease in US

Podcast (Video Recorded Lecture Series): Portal HTN and Derivatives for the USMLE Step One Exam. Ultrasound (w/ doppler) Reversal of flow Portal Vein

CHAPTER 7. End Stage Liver Disease in the ICU: Walking a Tightrope. Lynn A. Kelso, MSN, APRN, FCCM, FAANP University of Kentucky College of Nursing

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem

CHAPTER 1. Alcoholic Liver Disease

Initial approach to ascites

Management of the Cirrhotic Patient in the ICU

Hepatic Encephalopathy

Renal Care and Liver Disease: Disease Trajectory and Hospice Eligibility

CIRRHOSIS Definition

Tranjugular Intrahepatic Portosystemic Shunt

Evidence-Base Management of Esophageal and Gastric Varices

PORTAL HYPERTENSION. Tianjin Medical University LIU JIAN

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

Management of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

Index. Note: Page numbers of article titles are in boldface type.

Michele Bettinelli RN CCRN Lahey Health and Medical Center

following the last documented transfusion; thereafter, evaluate the residual impairment(s).

Management of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University

HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management

Nursing Care & Management of the Pre-Liver Transplant Population. Christine Kiamzon, RN, MSN, PCCN 8 North Educator

Nursing Care & Management of the Pre-Liver Transplant Population

Learning Objectives. After attending this presentation, participants will be able to:

CONTROLLED DOCUMENT. Cirrhosis Care Bundle CATEGORY: Clinical Guidelines. CLASSIFICATION: Clinical. Controlled Document CG201 Number:

CrackCast Episode 28 Jaundice

4/3/2014. Elizabeth Thompson, PharmD April Understand the importance of the liver and basic physiology.

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

Course Handouts & Post Test

Liver Failure. The most severe clinical consequence of liver disease is liver failure:

BRTO /PARTO Indications and outcomes

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed?

Acute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018

Entrustable Professional Activity

GI bleeding in chronic liver disease

Gastrointestinal System: Accessory Organ Disorders

הצגת מקרה- מפגש מכונים מאי 2017

Alzheimer s Disease, Dementia, Related Disorders

Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL

COMPLICATIONS OF CIRRHOSIS: ASCITES & HEPATIC ENCEPHALOPATHY

Index. Note: Page numbers of article titles are in boldface type.

Alcoholic Hepatitis: Routine Screening for Early Recognition and Management. Juan Guerrero, MD

Liver Diseases. Yasmine Lashine MD, PhD

Topics to be covered

Update in abdominal Surgery in cirrhotic patients

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Dialyzing challenging patients: Patients with hepato-renal conditions

ASCITES. Dr KS Cheung Queen Mary Hospital

Transjugular Intrahepatic

BETA-BLOCKERS IN CIRRHOSIS.PRO.

Ontario s Adult Referral and Listing Criteria for Liver Transplantation

Managing Cirrhosis. Cirrhosis of the liver is a progressive, fibrosing. Ascites. By Cameron Ghent, MD, FRCPC. Complications of Cirrhosis

Diagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion

Hepatic dysfunction: Can we recognize it sooner? And intervene earlier

Hepatology cases for the generalist. Will Gelson Consultant Hepatologist Addenbrooke s Hospital

Endovascular Techniques for Symptomatic Portal Hypertension. Michael Meuse, M.D. Vascular and Interventional Radiology

February 1, 2016 Body Fluid order changes

PACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen

Gastrointes*nal and Liver Pathology. Kris*ne Kra5s, M.D.

Life After SVR for Cirrhotic HCV

Evaluating HIV Patient for Liver Transplantation. Marion G. Peters, MD Professor of Medicine University of California San Francisco USA

Liver Transplantation Evaluation: Objectives

PACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:

Program Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals.

RENAL DISEASE IN END STAGE LIVER DISEASE

Complication of Portal Hypertension: should the patients in the waiting list be treated differently?

Beta-blockers in cirrhosis: Cons

Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate

Faculty Disclosure. Objectives. Cirrhosis Management for the Family Physician 18/11/2014

Current Liver Allocation Policies

Approach to the Patient with Liver Disease

Transcription:

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide

Overview DX Cirrhosis and Prognosis Compensated Decompensated

Complications Of Cirrhosis Management Of Complications 1. Ascities/ Peripheral edema 2. Variceal Bleeding 3. Spontaneous Bacterial Infection 4. Hepatic encephalopathy 5. Hepatocellular carcinoma 6. Hepato renal syndrome

Cirrhosis Late Stage of hepatic fibrosis distortion of hepatic architecture and formation of regeneration nodules. Considered an irreversible in advanced stage

Histology of the Liver

Cirrhosis 25,000 deaths and 370,000 hospital admissions 9th leading cause of death Common final pathway disease progression Chronic Hep C 28% alcohol 20% alcohol + Chronic Hep C 15% crypotogenic (NASH) 18% Hep B 15% Other 5% morbidity mortality associated with complication of decompensated disease

Natural Hx of Chronic Liver Disease CLD Compensated Decompensated Cirrhosis Death Decompensated Cirrhosis Portal HTN Jaundice Ascities Hepatic encephalopathy GI Bleeding

Survivor of Cirrhosis Compensated- mean 10 years Decompensated- mean 1.5 years (worse than metastatic colon cancer)

Portal HTN Healthy liver can accomodate changes portal blood flow Occurs combination increased portal venous flow and resistance to portal flow

Portal HTN 1. Nitric oxide low PV Resistance 2. Cardiac output mesenteric circulation 3. Blood pooling occurs portal circulation collagen deposition. Sinudoidal increased pressure residence

DIAGNOSIS DIAGNOSIS OF CIRRHOSIS PHYSICAL EXAM 1. ASCITIES 2. CAPUT MEDUSA COLLATERAL CIRCULATION 3. ASTERIXIS 4. GYNECOMASTIA, ESTROGEN METABOLISM 5. HEPATOMEGALY 6. JAUNDICE 7. SPIDER ANGIOMA 8. SPLENOMEGALY

Laboratory 1. Low Albumin 2. High Bili 3. Low Platelet count 4. Elevated Pt/INR 5. Liver Fibrosis Score 6. No Need Liver Bx at all times

IMAGING IMAGING CT SCAN OF ABD ASCITIES NODULAR LIVER U/S OF LIVER DETECTS 100CC ASCITIES

CHILDS SCORE CLASSIFICATION CHILDS SCORE POINTS 1-3 ENCEPHALOPATHY NONE GRADE 1-2 GRADE 3-4 ASCITIES NONE MILD - MOD SEVERE BILI < 2 2-3 > 3 ALB > 3.5 2.8-3.5 < 2.8 PT PROLONGED < 4 4-6 >6

CHILDS CLASS CLASSIFICATION CLASS A 5-6 POINTS CLASS B 7-9 POINTS CLASS C 10-15 POINTS

MELD SCORE MELD SCORE NO CLINICAL SUBJECTIVITY LAB EVAL, BILI CREATININE, INR CALCULATION RANGE 6-40 POINTS 3 MONTH SURVIVAL RATES 90 % - 7% WITHOUT TRANSPLANT

Ascities 1. Cirrhosis 80% mortality mean 1.6 years years 2. Malignancy 10% (ovarian pancreas) mortality mean 20 weeks 1. CHF mortality mean 2 years 2. Dialysis (Iron Infusions) mortality mean 7 months 3. TB 4. Other; Pancreatitis

Ascities 1. Water and Sodium retention ascities developes 2. Poor prognosis refractory ascities 50% survival at 6 months 3. Consider liver transplant

Dx ascities 1. Physical exam 2. Imaging best experts on PE: 50% correct 3. U/S detect 100 mls ascities

Diagnostic paracentesis 1. 30-50 ml 2. CHR/ Cirrhosis/ malignancy 3. r/o SBP

Spontaneous Bacterial Peritonitis 1. Paracentesis No Contraindication High INR if INR>4?? Low Platelets Same Complication rate 2. Complication 1 in 1000 hemoperitoneum

PARACENTESIS INITIAL STUDIES ASCITIC FLUID 1. CELL COUNT PMN > 250 2. PROTEIN LEVEL, 3. SAAG LEVEL SERUM ALB - ASCITIC ALB LEVEL 4. CYTOLOGY 5. CULTURE, GRAM STAIN 6. AMYLASE FOR PANCREATIC MAILGNANCY PANCRATITIS

SAAG SAAG CALCULATION SERUM ALB - ASCITIC ALB 1. IF > 1.1 PORTAL HTN, LIVER DISEASE, CIRRHOSIS ( LOW PROTEIN), CHF CARDIAC ( PROTEIN HIGH ), LIVER CANCER BUDD CHARI, PORTAL VEIN THROMBOSIS 1. IF < 1.1. NOT PORTAL HTN, PERITONEAL TB, NEPHROTIC SYNDROME PERITONEAL CARCINOMATOSIS ( HIGH PROTEIN), PANCREATITIS, BILIARY ASCITIES

TREATMENT MANAGEMENT OF ASCITIES 1. SODIUM RESTRICTION, < 2 GM DAY 2. H20 RESTRICTION IF HYPONATREMIA 3. DIURETICS LASIX 40 MG ( MAX 140MG], ALDACTONE 100MG ( MAX 400MG) 4. FOLLOW BMP 5. ALDACTONE TAKES 2-3 WEEKS EFFECT 6. CAUTION RENAL INSUFF

ASCITIES REFRACTORY ASCITIES 1. LARGE VOL PARACENTESIS Q 2 WEEKS, 10-12 LITERS 2. LOW NA DIET COMPLIANCE? 3. ALBUMIN INFUSION IF > 6 LITERS, 25 GM - 100 GM INFUSION

Spontaneous bacterial peritonitis Pathogenesis translocation into mesenteric lymph nodes s/p esophageal variceal banding and bleeding

SPONTANEOUS BACTERIAL PERITONITIS Symptoms Fever, jaundice,confusion, abd pain, hypotension No symptoms Higher childs class score more likely SBP S/P ESOPHAGEAL VARICEAL BANDING BLEEDING

Dx of SBP 1. If > 250 PMN s on paracentesis 2. Culture negative SBP 3. Culture positive but low PMN early SBP recommend RX

Secondary bacterial peritonitis 1. Ruptured DUODENAL ulcer 2. Pyelonephritis 3. Surgery risky but necessary, polymicrobial etiology

Repeat Paracentesis 1. Not needed if improved 2. Repeat if course worsens or not improving

Antibiotic RX 1. Start before culture 2. Cefotaxime ceftiaxone 3. PCN allergery cipro or levaquin 4. RX 5-10 days

Renal dysfunction to SBP 1. Follow creatinine 2. Paracentesis + albumin + antibiotics helpful reduces mortality 3. If variceal bleed give antibiotics + paracentesis + albumin

Hepatic encephalopathy 1. Altered brain function 2. Nitrogenous waste by colonic bacteria 3. Shunting of nitrogenous waste

Types of HE 1. Type A tylenol overdose Acute hepatitis no effect with xifaxin or lactulose 2. Type B Portosystemic bypass / Nl Liver 3. Type C cirrhosis portal HTN, main RX XIFAXIN/ Lactulose

Clinical dx 1. Ammonium level??? no need, elevated in obvious HE later stages 2. Poor correlation with dx 3. Follow clinical response

Stages of HE 1. Stage 0-4 Stage 1 drunk Stage 2 drowsy Stage 3 somnolence Stage 4 comatose 2. Stage 0-2 Nl levels but + HE

Precipitating etiology of HE 1. GI variceal bleeding 2. TIPS 3. Infections SBP 4. Constipation 5. Electrolyte imbalance 6. Sedatives

Treatment HE 1. Lactulose - changes PH increase 5.0 ammonia to ammonium 2. Xifaxan 550 BID 3. Rx; precipaitating cause GI bleeding electrolyte imbalance

Gastroesophageal varices 1. Present 50% of pt cirrhosis, 40% of child A, 85% of child C 2. Develop rate 8% a year - EGD every 3 years (dynamic process) 3. Risk bleeding 5-15% each year increase with size/ child class 4. Mortality with bleeding > 20% @ 6 weeks 5. Stop spontaneously in 40% patients

treatment 1. Small varices B blocker 2. Large varices Banding or B Blocker (old rx sclerotherapy injection )

Acute GI Bleed 1. Octreotide / ICU / IV fluid 2. PPiI,? ulcer or other bleeding site 3. Antibiotics 4. EGD banding in 12 hours?? 5. Correct coagulopathy - vit k - FFP - platelets 6. Failure of endoscopy - TIPS - Balloon tamponade ( old treatment ) 7. BRTO (Balloon retrograde transvenous obliteration ) For gastric varices - femoral vein approach

Antibiotics Prophylaxis 1. Improves morbidity and repeat bleeding 2. SBP can occur with variceal bleeding 3. Pneumonia / bacteremia from variceal bleeding 4. Transfusion requirement improved 5. Bacterial infection after bleeding 40% mortality

Renal Injury Cirrhosis 1. Hepatorenal syndrome, dx of exclusion 2. Dehydration pre renal etiology 68% causeof renal dysfunction 3. Survival is decreased with renal dysfunction 4. Hepatorenal syndrome median survival 3 month if not transplanted

REFERENCES GUT: ACUTE ON CHRONIC LIVER FAILURE; 2017, MAR, 66( 3), 541-553 JOURNAL OF BIOMEDICAL RESEARCH, (3): 1-18, OCT 2016 Dr. Steven - Huy Han, lecture on complications of cirrhosis Kevin kolendich MD, lecture on cirrhosis complication Dr. Melissa Haines MD, lecture Management of CLD